PoliticalRepoPoliticalRepo

United States · Law · HR

H.R. 1193 (117th)

Cardiovascular Advances in Research and Opportunities Legacy Act

enactedUnited States· United States Congress· EN

Introduced

22 February 2021

Last action

—

Status

Became Public Law No: 117-244.

Sponsors

—

Subjects

Discovery layer

Source updated

6 December 2025

Official sourceDownload fileView documentsShare

Summary

Cardiovascular Advances in Research and Opportunities Legacy Act This bill expands research on valvular heart disease and its treatment. This disease is caused by damage to or disease affecting any valve that controls blood flow in the heart. The National Institutes of Health must consult with the National Heart, Lung, and Blood Institute to conduct or support research on the disease, including on mitral valve prolapse. This occurs when the valve between the chambers of the left side of the heart seals improperly. The Centers for Disease Control and Prevention (CDC) must develop best practices to treat valvular heart disease. The CDC may also carry out other projects to increase awareness of and reduce deaths from the disease.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

24 official files

Enrolled Bill (text)

View fileDownload file

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.